These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9602182)

  • 41. Hypercalcuria and metabolic bone disease.
    ROSENBERG ML
    Calif Med; 1954 Dec; 81(6):382-90. PubMed ID: 13209371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial absorptive hypercalciuria in a large kindred.
    Pak CY; McGuire J; Peterson R; Britton F; Harrod MJ
    J Urol; 1981 Dec; 126(6):717-9. PubMed ID: 7321108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome.
    Thakker RV
    Exp Nephrol; 2000; 8(6):351-60. PubMed ID: 11014932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial forms of hypercalciuria.
    Favus MJ
    J Urol; 1989 Mar; 141(3 Pt 2):719-22. PubMed ID: 2645430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A common molecular basis for three inherited kidney stone diseases.
    Lloyd SE; Pearce SH; Fisher SE; Steinmeyer K; Schwappach B; Scheinman SJ; Harding B; Bolino A; Devoto M; Goodyer P; Rigden SP; Wrong O; Jentsch TJ; Craig IW; Thakker RV
    Nature; 1996 Feb; 379(6564):445-9. PubMed ID: 8559248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria.
    Lerolle N; Lantz B; Paillard F; Gattegno B; Flahault A; Ronco P; Houillier P; Rondeau E
    Am J Med; 2002 Aug; 113(2):99-103. PubMed ID: 12133747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dent's disease: hereditary nephrolithiasis related to defective tubular endocytosis processes].
    Tosetto E; Anglani F; Graziotto R; Citron L; D'Angelo A; Gambaro G
    G Ital Nefrol; 2003; 20(6):578-88. PubMed ID: 14732909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
    Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Having rs1042636C677T calcium-sensing receptor polymorphism: Increased or decreased risk for nephrolithiasis?
    Yasri S; Wiwanitkit V
    Saudi J Kidney Dis Transpl; 2018; 29(3):743-744. PubMed ID: 29970760
    [No Abstract]   [Full Text] [Related]  

  • 50. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.
    Rendina D; Mossetti G; Viceconti R; Sorrentino M; Castaldo R; Manno G; Guadagno V; Strazzullo P; Nunziata V
    Urology; 2004 Oct; 64(4):833-8. PubMed ID: 15491743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of the degree of saturation of calcium hydrogen phosphate in the urine].
    Reusz G; Szabó A; Tulassay T
    Orv Hetil; 1989 Mar; 130(11):565-8. PubMed ID: 2927936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and clinical studies of Dent's disease in Japan: biochemical examination and renal ultrasonography do not predict carrier state.
    Matsuyama T; Awazu M; Oikawa T; Inatomi J; Sekine T; Igarashi T
    Clin Nephrol; 2004 Apr; 61(4):231-7. PubMed ID: 15125028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis.
    Hemal AK; Sidhu H; Thind SK; Nath R; Vaidyanathan S
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):44-6. PubMed ID: 2744906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
    Horváth C; Németh J; Büki B; Vargha P
    Orv Hetil; 1990 Nov; 131(45):2475-8. PubMed ID: 2234941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypercalciuric rickets: a rare cause of nephrolithiasis.
    Salti IS; Hemady K
    Nephron; 1980; 25(5):222-6. PubMed ID: 6247664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Progress in diagnosis and treatment of hypercalciuric urinary calculi].
    Raszeja-Wanic B
    Pol Arch Med Wewn; 1979 Nov; 62(5):381-90. PubMed ID: 530863
    [No Abstract]   [Full Text] [Related]  

  • 57. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathophysiological studies in hypercalciuric and normocalciuric stone formers.
    Minisola S; Scarda A; Medori C; Valtorta C; Antonelli R; Tabolli S; Rossi W; Mazzuoli G
    Urol Int; 1985; 40(2):65-71. PubMed ID: 3992738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Osteocalcin in normo- and hypercalciuric renal lithiasis: no evidence of change].
    Rico H; Yagüe M; Páramo P; Usón A; Cabranes JA
    Arch Esp Urol; 1987; 40(6):416-8. PubMed ID: 3499872
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis.
    Negri AL; Spivacow R; Del Valle E; Fradinger E; Marino A; Zanchetta JR
    Urol Res; 2003 Dec; 31(6):378-81. PubMed ID: 13680023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.